ResMed Inc.

RSMDF ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2010 FY2009
Operating Activities
Net Income $190.1M $146.4M
Depreciation & Amortization $61.6M $54.0M
Depreciation — —
Amortization $8.0M $7.1M
Stock-Based Compensation $29.7M $25.5M
Net Cash from Operating Activities $188.2M $238.9M
Investing Activities
Capital Expenditures $56.9M $109.7M
Business Acquisitions $10.7M $2.4M
Net Cash from Investing Activities $-58.3M $-109.3M
Financing Activities
Dividends Paid — —
Stock Repurchases $131.1M $68.6M
Net Cash from Financing Activities $-61.1M $1.9M
Net Change in Cash $73.1M $94.6M
Free Cash Flow $131.4M $129.2M
← Newer Page 3 of 3 Older →